[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"respiratory-monitoring\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:respiratory-monitoring":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,47,76],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100642211","respiratory-observation-using-ultra-sensitive-nanotechnology-100642211",false,"NCT07650539","Respiratory OBservation Using Ultra-Sensitive nanoTechnology","Respiratory Observation Using Ultra-Sensitive Nanotechnology","ROBUST","Inclusion Criteria:\n\n* Have capacity to consent to the study\n* Undergoing surgery or receiving oxygen therapy\n\nExclusion Criteria:\n\n* Inability to wear the monitor as designed","ALL","18 Years",{"count":20,"type":21},148,"ESTIMATED","INTERVENTIONAL",[24],"NA","The Problem - About one in three patients get even more sick while they are in hospital. This often happens because of chest infections, sepsis (very serious infection), or heart problems. These illnesses can make it hard to breathe. They are even more dangerous when patients already have breathing problems.\n\nNurses and doctors need to spot when someone is getting worse as early as possible, so they can help them. For example, giving medicines quickly for sepsis can save lives. Sometimes it's hard to tell when someone is getting worse. Sometimes it's noticed too late. This can be very dangerous. In 2023, nearly 8,000 people died because their illness wasn't spotted quickly enough.\n\nEven if patients don't die, they might need longer in hospital and more care. This costs the NHS a lot more money. It also means fewer beds for other patients. Finding better ways to spot these problems early is an important goal.\n\nThe Opportunity - Research shows checking patients more often helps spot problems early. Nurses do many routine checks. These include blood pressure, temperature, heart rate and oxygen levels.\n\nNurses also check the breathing rate (the number of breaths per minute). Breathing rate is the best way to tell if someone is getting sicker. But it is also the hardest to measure properly. The machines we have don't do it well. So, nurses stand by the patient and count how fast they are breathing. This takes time and can be wrong if the patient talks or moves. Sometimes, it's not done at all.\n\nThe Need - Breathing rate is very useful. But we don't have good tools to measure it easily. We need something simple and accurate. It should also be comfortable for patients and fit into normal hospital care.\n\nOur New Idea - RespiraFibre - We've made a new device called RespiraFibre. It's a tiny, smart sensor. It attaches to the oxygen masks or tubes that patients already wear. It can tell how the patient is breathing. If something is wrong, it sends a warning to the nurse or doctor.\n\nIn this project, we will:\n\n1. Work with patients to make sure the RespiraFibre is comfortable.\n2. Make sure hospital staff find it easy to use.\n3. Test how accurate it is.\n4. Try it out on real hospital wards.\n5. Get it ready to use in hospitals across the country.\n\nThe Impact - We want to treat patients fast if they get sick. To do this, we need early warnings if things are getting worse. This will lead to better care, fewer deaths, and lower costs for the NHS. Our work with RespiraFibre will help make this happen.",[27],"Respiratory Monitoring",[29,30,31,32,33],"Nanotechnology sensor","Continuous respiratory monitoring","Clinical deterioration detection","Validation study","Feasibility study","NOT_YET_RECRUITING","2026-06-10",{"date":37,"type":38},"2026-06-16","ACTUAL",{"date":40,"type":21},"2026-08",{"date":42,"type":21},"2029-02",{"name":44,"class":45},"University College, London","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":57,"briefSummary":58,"conditions":59,"keywords":62,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":46},"100606240","the-value-of-standardized-respiratory-rate-monitoring-exercises-during-rheumatological-injection-procedures-100606240","NCT07172984","The Value of Standardized Respiratory Rate Monitoring Exercises During Rheumatological Injection Procedures","The Value of Standardized Respiratory Rate Monitoring Exercises During Rheumatological Infiltration Procedures - A Single-blind, Randomized, Controlled Non-inferiority Study","Respi-IR","Inclusion Criteria:\n\n* Patient scheduled to undergo therapeutic ultrasound-guided joint or periarticular injection.\n* Patient able to sign an informed consent form to participate in the study\n\nExclusion Criteria:\n\n* Patient able to sign an informed consent form to participate in the study - - Allergy to the injection product or anesthetic.\n* Injection not allowing the use of a local anesthetic due to insufficient joint volume (e.g., fingers\u002Ftoes).\n* Epidural injection via the sacrococcygeal hiatus.\n* Pregnant women",{"count":56,"type":21},136,[24],"The goal of this clinical trial is to demonstrate the non-inferiority of standardized breathing control exercises on perceived pain during rheumatological injections procedures compared to standard care consisting of the addition of a local anesthetic. The study population will consist of patients scheduled to undergo therapeutic ultrasound-guided joint or periarticular injection. The main question it aims to answer is:\n\n* Non-inferiority of breathing exercises compared to the addition of local anesthetic on pain and anxiety experienced during an infiltration procedure.\n* Correlation between the reduction in pain and anxiety experienced during a procedure and the cardiac coherence score obtained.\n\nResearchers will compare the anesthesia group (Arm A), which will receive local anesthesia with 5 cc of lidocaine before the infiltration procedure to the breathing group (Arm B), which will receive instructions before the injection procedure on how to perform 5-minute breathing cycles to facilitate the achievement of cardiac coherence to see if the pain perceived in Arm B is not greater than the pain perceived in Arm A.\n\nParticipants will be kept blind to their randomization group. Arm A (anesthesia) will receive SHAM breathing exercises, while Arm B (breathing) will receive a placebo injection of anesthetic.",[60,61,27],"Rheumatological Injection","Pain Management",[63,64,65],"rheumatological injection","local anesthesia during intra-articular injection","respiratory rate monitoring","RECRUITING","2025-12-30",{"date":69,"type":38},"2026-01-05",{"date":71,"type":38},"2025-09-19",{"date":73,"type":21},"2028-09-20",{"name":75,"class":45},"Centre Hospitalier Metropole Savoie",{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":84,"targetDuration":86,"studyType":87,"phases":4,"briefSummary":88,"conditions":89,"keywords":93,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":46},"100586774","early-lung-function-trajectories-comparison-between-infants-with-and-without-intrauterine-growth-restriction-100586774","NCT06919757","Early Lung Function Trajectories: Comparison Between Infants With and Without Intrauterine Growth Restriction.","Early Lung Function Trajectories: Comparison Between Infants With Intrauterine Growth Restriction and Appropriately Grown Ones.","ELFIGO","Inclusion Criteria:\n\n* Fetuses and Infants born before 32 weeks of gestation, with and without fetal growth restriction\n\nExclusion Criteria:\n\n* Lack of informed consent\n* Need for palliative care\n* Major malformations",{"count":85,"type":21},54,"2 Years","OBSERVATIONAL","During intrauterine life, some babies are smaller or grow less than expected. This fetal growth abnormality, called fetal growth restriction (FGR), can be diagnosed by ultrasound. Since there are currently no curative treatments for this condition, nor methods to optimize the growth of babies in the womb, the only effective strategy is intensive monitoring of fetal conditions, accompanied by early planning of delivery.\n\nThe diagnosis of early FGR (i.e. diagnosed before 32 weeks of gestation) confers a greater risk of short- and long-term respiratory problems.\n\nThe study aims to examine the association between parameters that can be assessed during pregnancy by ultrasound, such as the estimate of lung volumes, the thickness and contractility of the diaphragm, and cardiac kinetics, and any perinatal complications and respiratory function in the first years of life of premature infants, both with and without evidence of fetal growth pathology. Therefore, the study is divided into two phases: a prenatal and a postnatal phase.\n\nThe study includes two groups of patients:\n\n1. Study group: Fetuses and preterm infants with a prenatal history of FGR;\n2. Control group: Preterm infants without a prenatal history of FGR followed during neonatal follow-up.\n\nPregnant women with fetuses with FGR are followed at the Ultrasound clinics dedicated to Growth Pathology.\n\nThese pregnancies usually receive weekly ultrasound monitoring, which includes a Doppler study of the maternal and fetal circulation and an estimate of fetal weight every two weeks. Cardiotocographic monitoring is also planned once or twice a week, depending on fetal well-being.\n\nThe child will be assessed from a respiratory point of view during hospitalization and subsequently in the outpatient clinic, as required by clinical practice.\n\nHe\u002Fshe will undergo respiratory function tests. Visits are scheduled at 3, 6, 12 and 24 months of corrected age, during which at least two respiratory function tests will be performed.\n\nIn addition, routine clinical data (personal data, medical history, blood tests, biological and instrumental tests) present in the medical record of the child will be collected.\n\nData from preterm infants without fetal growth restriction will be collected after informed consent. These infants are routinely followed at our Institution and undergo clinical assessment and lung function tests in the first two years of life as previously indicated.",[90,91,92,27],"Intrauterine Growth Retardation (IUGR)","Lung Function Tests","Preterm Infant",[94,95,96,97,98],"lung volume measurements","pulmonary function test","preterm birth","intrauterine growth retardation","oxygen saturation\u002Fphysiology","2025-08-25",{"date":101,"type":38},"2025-08-26",{"date":103,"type":38},"2025-04-20",{"date":105,"type":21},"2027-03",{"name":107,"class":45},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS"]